STOK

Stoke Therapeutics Inc.

Price

$33.03

return (12m)

78.64%

p/e

-9.83

p/bv

5.91

DIVIDEND YIELD

0.00%

STOK price

Stoke Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment STOK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.59%

3 months

11.32%

1 year

78.64%

2 years

122.57%

5 years

32.65%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals STOK

Valuation

P/E

-9.83

Sector -4.38

Industry -4.38

P/BV

5.91

Sector 2.02

Industry 2.02

P/Revenue (PSR)

74.08

Sector -4.40

Industry -4.40

EV/EBITDA

-26.94

Sector -263.09

Industry -263.09

EV/EBIT

-26.75

Sector -702.90

Industry -702.90

P/EBITDA

-9.22

Sector -4.39

Industry -4.39

P/EBIT

-9.15

Sector -4.73

Industry -4.73

P/Total Assets

5.19

Sector 1.49

Industry 1.49

P/Net Current Assets

7.45

Sector -11.70

Industry -11.70

P/Working Capital

7.28

Sector -3.19

Industry -3.19

EPS

-3.15

Sector -2.14

Industry -2.14

BVPS

5.24

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-697.10%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-702.04%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.02

Sector 0.03

Industry 0.03

Profitability

ROE

-60.16%

Sector -65.14%

Industry -65.14%

ROA

-52.77%

Sector -65.53%

Industry -65.53%

ROIC

-284.86%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.69

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.51

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.48

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.85

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.88

Sector 0.41

Industry 0.41

Liabilities/Assets

0.12

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

19.36%

Sector -

Industry -

Fundamentals STOK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
STOK Stoke Therapeutics Inc.	$33.03	78.44%	0.00%	-9.83	5.91	-60.16%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

STOK Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Stoke Therapeutics

Stoke Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

12 years

Founded: 2014

2019

Time since IPO - 7 years

79

Employees

Stoke Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.04 billion, with shareholders equity totaling $345.55 million.

The company employs approximately 79 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Stoke Therapeutics Inc. reported $27.58 million in revenue, generating net income of $-207.90 million.

Key financial metrics include a P/E ratio of -9.83, a price-to-book (P/B) ratio of 5.91, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker STOK.

Market cap

$2.04 billion

Net worth

$345.55 million

$345,550,000.00

Assets

$393.97 million

$393,970,000.00

Total Shares Outstanding

66.00 million

66,000,000

Average Daily Trading Volume

$865.21 Thousand

$865,209.90

Sector

Health Care

Industry

Biotechnology

STOK

STOK revenue and profits

Financial Results STOK

DRAG THE FRAME TO SEE MORE DATA

STOK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Stoke Therapeutics (STOK) today?

A cotação de Stoke Therapeutics (STOK) hoje está em US$ 33.03, com uma variação de 78.64% em relação ao último ano. A cotação de Stoke Therapeutics (STOK) iniciou o ano negociando na casa dos US$ 31.74 e hoje está em US$ 33.03. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Stoke Therapeutics (STOK) e dados de ações do Ibovespa e mercados internacionais.

Quando Stoke Therapeutics (STOK) paga dividendos?

Stoke Therapeutics (STOK) não distribuiu dividendos no último ano.

Is Stoke Therapeutics (STOK) a good investment?

Atualmente, Stoke Therapeutics (STOK) está cotada a US$ 33.03, com um P/L de -9.83, representando um desvio de -6,187% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 78.64 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 78.64%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Stoke Therapeutics (STOK) stock?

Investir em ações de Stoke Therapeutics (STOK) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Stoke Therapeutics (STOK) yield today?

A rentabilidade de Stoke Therapeutics (STOK) foi de 19.59% no último mês, 78.64% no último ano e 32.65% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Stoke Therapeutics (STOK) hoje, o investimento total seria de US$ 3,303.00, com base na cotação atual de US$ 33.03.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5,900.48
Em 5 anos: US$ 4,381.43
Em 10 anos: US$ 3,303.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

STOK

Stoke Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment STOK

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING STOK WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Stoke Therapeutics

Stoke Therapeutics Inc.

United States

12 years

2019

79

PROFIT X PRICE STOK

Financial Results STOK

STOK cash flow

Asset, Revenue and Profit Growth - STOK

STOK balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions